Peer-influenced content. Sources you trust. No registration required. This is HCN.
The New England Journal of Medicine
Dupilumab significantly induced histologic remission in 68% of children with eosinophilic esophagitis compared to 3% in the placebo group, according to a phase 3 trial.
Gastroenterology July 10th 2024
CME 
JOBS 
OUTBREAKS 
PEER-TO-PEER 
QUIZZES & QUESTIONS 
MEDTECH